Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Biotechnology strategy

Even on the rather simplified arguments described here, it should be clear that biotechnological approaches are generally more environmentally friendly and that we can apply biotechnological strategies to inorganic, as well as organic chemicals. We... [Pg.7]

Table 23.2 Main drawbacks during microbial flavour production and biotechnological strategies to address them... [Pg.511]

The most important of the aforementioned flavour-enhancing nucleotides are inosine 5 -monophosphate (IMP) and guanosine 5 -monophosphate (GMP), of which about 2,000 and 1,000 t year are produced by biotechnological processes worldwide [22] and which are used as their disodium salts. The nucleotides contribute to the flavour-enhancing effect brought into food by yeast hydrolysates. Diflerent biotechnological strategies have been developed for the production of pure nucleotides ... [Pg.516]

Scheme 23.7 Biotechnological strategies for the production of natural raspberry ketone... Scheme 23.7 Biotechnological strategies for the production of natural raspberry ketone...
In addition to individual businesses, chemical companies have to consider their biotechnology strategies from the point of view of a portfolio and the synergies it offers. The example of the life science companies shows that biotechnology does not contain synergies right across the board, but there are important ones which conglomerates or Hfe science companies can use as a basis for portfolio selection. [Pg.76]

The number of alkaloids which have been produced on an industrial scale through new biotechnological strategies is still rather small. There are three interrelated categories of problems hampering the development... [Pg.20]

Sahdev, S, Khattar, S.K., and Saini, K.S. (2008) Production of active eukaryotic proteins through bacterial expression systems a review of the existing biotechnology strategies. Mol. Cell. Biochem., 307, 249-264. [Pg.179]

Juarez del Valle, M., Laino, J.E., de Giori, G.S., and LeBlanc, J.G. (2014) Riboflavin producing lactic acid bacteria as a biotechnological strategy to obtain bio-enriched soymilk. Food Res. Int., 62, 1015-1019. [Pg.440]

Giulietti, A. M. and Ertola, R. J. (1997) Biotechnological strategies for production of plants and secondaiy metabolites of pharmaceutical interest. In Second word congress on medicinal and aromatic plants for human welfare WOCMAP-2 (Giberti, G., ed.) ds.). pp. 269-280, ISHS, Mendoza, Argentina. [Pg.149]

Many biotechnological strategies have been taken and put into practice for improving the production of secondary metabolites from medicinal plants. These include screening for high yielding cell lines, media modification, precursor feeding, and elicitation treatment. ... [Pg.173]

Parawira, W. and Tekere, M. (2011) Biotechnological strategies to overcome inhibitors in lignocellulose hydrolysates for ethanol production review. CrU. Rev. Biotechnol, 31 (1), 20-31. [Pg.388]

Many plant biotechnological strategies are directed towards introducing fundamental changes in Ae properties of (woody) plant cell walls and their biopolymers. Alternatively, other approaches attempt to alter levels of specific constituents such as those imparting defense functions. The purposes of such manipulations are manifold To optimize wood properties for lumber and paper production, to produce new biopolymers which are expected to be valuable as replacements for petroleum-derived polymers, to alter nutritional qualities of foodstuffs, to increase the production of pharmacologically important compounds, and to either introduce or enhance novel defense functions in plants (i.e., antioxidants, biocidal properties and the like). Such approaches, in fact, represent exploitation of ongoing evolutionary processes by calculated human intervention. [Pg.203]

It was shown that Lact. plantarum CRL 725 was able to increase 2-fold the initial concentration of riboflavin in soymilk (Juarez del Valle et al. 2014). Roseoflavin-resistant variants of this strain were also obtained and evaluated in soymilk. One of the variants obtained was able to increase 6 times (1860 20 ng Bj/ml) the basal riboflavin levels of so3nnitk. Roseoflavin-resistant strains capable of synthesizing riboflavin in soymilk constitute an interesting and economically feasible biotechnology strategy that could be adapted by the food industry to develop novel vitamin-bioenriched functional foods with enhanced consumer appeal. [Pg.283]


See other pages where Biotechnology strategy is mentioned: [Pg.201]    [Pg.406]    [Pg.211]    [Pg.511]    [Pg.533]    [Pg.554]    [Pg.343]    [Pg.233]    [Pg.580]    [Pg.582]    [Pg.7]    [Pg.7]    [Pg.28]    [Pg.386]    [Pg.189]    [Pg.214]    [Pg.336]    [Pg.337]    [Pg.337]    [Pg.228]    [Pg.135]    [Pg.163]    [Pg.91]    [Pg.462]    [Pg.1686]    [Pg.1691]    [Pg.572]    [Pg.508]    [Pg.107]    [Pg.92]    [Pg.138]   
See also in sourсe #XX -- [ Pg.381 , Pg.382 , Pg.383 ]




SEARCH



© 2024 chempedia.info